Technical Analysis for LXEO - Lexeo Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 15.61 | -2.68% | -0.43 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Shooting Star Candlestick | Bearish | 0.00% | |
| New Uptrend | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | -2.68% | |
| Volume Surge | Other | -2.68% | |
| Gapped Up | Strength | -2.68% | |
| Crossed Above 50 DMA | Bullish | 5.05% | |
| Hammer Candlestick | Bullish | 5.05% | |
| Lizard Bullish | Bullish Day Trade Setup | 5.05% | |
| Pocket Pivot | Bullish Swing Setup | 5.05% |
| Alert | Time |
|---|---|
| Reversed from Up | about 4 hours ago |
| Possible Pocket Pivot | about 4 hours ago |
| 20 DMA Resistance | about 7 hours ago |
| Up 1 ATR | about 9 hours ago |
| 60 Minute Opening Range Breakout | about 9 hours ago |
Get a Trading Sidekick!
- Earnings date: 02/28/2024
Lexeo Therapeutics, Inc. Description
Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020 to treat ARVC caused by mutations in the PKP2 gene; LX2021 to treat DSP Cardiomyopathy associated with Cx43 deficiency; and LX2022 to treat HCM associated with mutations in the TNNI3 gene. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of POE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Disease Rare Diseases Gene Therapy Applied Genetics Cardiomyopathy Lipid Storage Disorders Ataxia Friedreich's Ataxia
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 22.33 |
| 52 Week Low | 9.0 |
| Average Volume | 176,512 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 14.94 |
| 20-Day Moving Average | 16.77 |
| 10-Day Moving Average | 15.88 |
| Average True Range | 1.27 |
| RSI (14) | 47.92 |
| ADX | 27.82 |
| +DI | 28.76 |
| -DI | 23.48 |
| Chandelier Exit (Long, 3 ATRs) | 15.33 |
| Chandelier Exit (Short, 3 ATRs) | 17.46 |
| Upper Bollinger Bands | 19.01 |
| Lower Bollinger Band | 14.53 |
| Percent B (%b) | 0.24 |
| BandWidth | 26.71 |
| MACD Line | 0.06 |
| MACD Signal Line | 0.36 |
| MACD Histogram | -0.2988 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 18.31 | ||||
| Resistance 3 (R3) | 18.59 | 17.98 | 17.86 | ||
| Resistance 2 (R2) | 17.98 | 17.29 | 17.84 | 17.71 | |
| Resistance 1 (R1) | 16.79 | 16.86 | 16.49 | 16.51 | 17.56 |
| Pivot Point | 16.18 | 16.18 | 16.02 | 16.04 | 16.18 |
| Support 1 (S1) | 14.99 | 15.49 | 14.69 | 14.71 | 13.66 |
| Support 2 (S2) | 14.38 | 15.06 | 14.24 | 13.51 | |
| Support 3 (S3) | 13.19 | 14.38 | 13.36 | ||
| Support 4 (S4) | 12.91 |
